Trump to invoke Defense Production Act if needed for vaccine distribution | Inquirer News

Trump to invoke Defense Production Act if needed for vaccine distribution

/ 06:32 AM December 09, 2020

U.S. President Donald Trump signs an executive order on vaccine distribution during an Operation Warp Speed Vaccine Summit at the White House in Washington, U.S., December 8, 2020. REUTERS/Tom Brenner

WASHINGTON — U.S. President Donald Trump said on Tuesday he would invoke the Defense Production Act if needed to ensure Americans are first in line for domestically produced coronavirus vaccines, although he added he did not think it would be necessary.

Trump delivered the remarks at the top of a White House summit on vaccine development and distribution just before signing an executive order intended to ensure that priority access for COVID-19 vaccines procured by the U.S. government is given to the American people before assisting other nations.

Article continues after this advertisement

The executive order does not appear to have a clear enforcement mechanism, so Trump’s suggestion that he could use the Defense Production Act was significant. The act, which was passed in 1950, grants the president the power to expand industrial production of key materials or products for national security and other reasons.

FEATURED STORIES

“If necessary … we’ll invoke the Defense Production Act, but we don’t think it will be necessary. If it is, it’s a very powerful act, as you know, because we’ve used it very, very successfully,” he said.

The executive order and the summit itself seemed designed in part to give credit to Trump, a Republican who lost the 2020 presidential election to Democrat Joe Biden but has refused to concede, for the speedy development of the vaccine.

Article continues after this advertisement

At the beginning of the event, a video was played showing people, including infectious disease expert Dr. Anthony Fauci, casting doubt on the likelihood a vaccine would be ready before the end of the year.

Article continues after this advertisement

Trump has had a complicated relationship with Fauci, who has been director of the National Institute of Allergy and Infectious Diseases since 1984. Biden has made him a chief medical adviser in his upcoming administration.

Article continues after this advertisement

The White House did not invite members of the Biden transition team to the vaccine summit. Biden’s administration will oversee vaccine distribution once he takes office on Jan. 20.

Trump, who has asserted allegations of widespread electoral fraud without evidence, repeated his claims when asked about why Biden officials had not been included.

Article continues after this advertisement

“We’re going to have to see who the next administration is, because we won in those swing states and there was terrible things that went on. … But whichever the next administration is will really benefit by what we have been able to do,” Trump said. “Hopefully the next administration will be the Trump administration.”

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.

TAGS: COVID-19, COVID-19 Vaccine, United States, White House

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.